![Pashtoon Kasi: With BOT/BAL in our NEST trial, we are seeing ctDNA decline and CLEAR within days to 2-4 weeks](https://oncodaily.com/pub/uploads/2023/09/D9C778F2-980C-43BE-A589-0AC3D47B79EE-e1715172563679.jpeg)
Photo from Pashtoon Kasi/LinkedIn
Mar 26, 2024, 15:02
Pashtoon Kasi: With BOT/BAL in our NEST trial, we are seeing ctDNA decline and CLEAR within days to 2-4 weeks
Pashtoon Kasi, Director for Colorectal Cancer Research at Weill Cornell Medicine shared on LinkedIn:
“We grossly underestimate how quickly immunotherapy can work. Especially with BOT/BAL (botensilimab) in our NEST trial, we are seeing ctDNA decline and CLEAR within days to 2-4 weeks. Unprecedented!
March is Colorectal Cancer Awareness Month.”
Proceed to the article.
Source: Pashtoon Kasi/LinkedIn
Jul 4, 2024, 00:09